Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study GC Dobloug, J Svensson, IE Lundberg, M Holmqvist Annals of the rheumatic diseases 77 (1), 40-47, 2018 | 133 | 2018 |
Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study J Svensson, EV Arkema, IE Lundberg, M Holmqvist Rheumatology 56 (5), 802-810, 2017 | 111 | 2017 |
Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case–control study J Svensson, M Holmqvist, IE Lundberg, EV Arkema Annals of the rheumatic diseases 76 (11), 1803-1808, 2017 | 68 | 2017 |
Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study L Dani, M Holmqvist, MA Martínez, E Trallero-Araguas, M Dastmalchi, ... Clinical and experimental rheumatology 38 (1), 67-73, 2020 | 23 | 2020 |
Registries in idiopathic inflammatory myopathies IE Lundberg, J Svensson Current Opinion in Rheumatology 25 (6), 729-734, 2013 | 22 | 2013 |
Venous thromboembolic events in idiopathic inflammatory myopathy: occurrence and relation to disease onset A Antovic, A Notarnicola, J Svensson, IE Lundberg, M Holmqvist Arthritis Care & Research 70 (12), 1849-1855, 2018 | 19 | 2018 |
Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study V Leclair, J Svensson, IE Lundberg, M Holmqvist The Journal of rheumatology 46 (11), 1509-1514, 2019 | 16 | 2019 |
Chronic pain after open inguinal hernia repair: expertise-based randomized clinical trial of heavyweight or lightweight mesh M Rutegård, M Lindqvist, J Svensson, P Nordin, MM Haapamäki British Journal of Surgery 108 (2), 138-144, 2021 | 13 | 2021 |
The Risk of Ischemic and Hemorrhagic Stroke in Patients With Idiopathic Inflammatory Myopathies: A Swedish Population‐Based Cohort Study J Moshtaghi‐Svensson, IE Lundberg, M Von Euler, EV Arkema, ... Arthritis care & research 71 (7), 970-976, 2019 | 12 | 2019 |
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies V Leclair, J Moshtaghi-Svensson, M Regardt, M Hudson, IE Lundberg, ... Seminars in Arthritis and Rheumatism 51 (5), 983-988, 2021 | 10 | 2021 |
Mobile multimedia service-surveying the preferences of young people M Lindqvist, J Svensson Proceedings of the 30th Information Systems Research Seminar in Scandinavia IRIS, 2007 | 9 | 2007 |
Exposure to oestrogen and risk of anastomotic leakage after colorectal cancer surgery–A clue to the different leak rates in men and women M Rutegård, J Moshtaghi‐Svensson, CE Weibull, U Ottander, ... Colorectal Disease 25 (1), 9-15, 2023 | 8 | 2023 |
Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment J Svensson, M Holmqvist, A Tjärnlund, M Dastmalchi, B Hanna, ... Clin Exp Rheumatol 35 (3), 512-5, 2017 | 8 | 2017 |
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study H Westerlind, M Bairkdar, K Gunnarsson, J Moshtaghi-Svensson, ... Seminars in Arthritis and Rheumatism 53, 151978, 2022 | 7 | 2022 |
Prevalence of Idiopathic Inflammatory Myopathies in Sweden in 2012-a National Register Study J Svensson, A Tjarnlund, IE Lundberg, M Holmqvist ARTHRITIS & RHEUMATOLOGY 67, 2015 | 1 | 2015 |
FRI0197 use of BIOLOGICS in PM and DM in Sweden-a national register study J Svensson, A Tjärnlund, J Askling, M Dastmalchi, B Hanna, SM Bucher, ... Annals of the Rheumatic Diseases 73 (Suppl 2), 453-454, 2014 | 1 | 2014 |
Corrigendum to" Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study"[Seminars in Arthritis and Rheumatism 53 (2022), 151978]. H Westerlind, M Bairkdar, K Gunnarsson, J Moshtaghi-Svensson, ... Seminars in Arthritis and Rheumatism, 152311-152311, 2023 | | 2023 |
Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products S Toghanian, J Moshtaghi-Svensson, M Papageorgiou, K Kittelsen, ... Journal of Health Economics and Outcomes Research 9 (1), 20, 2022 | | 2022 |
Anti-Transcriptional Intermediary Factor 1-gamma Antibodies in Dermatomyositis with and Without Cancer-A Longitudinal Study L Dani, S Selickaja, AS Galindo-Feria, J Svensson, P Venalis, D Leonard, ... ARTHRITIS & RHEUMATOLOGY 73, 1412-1413, 2021 | | 2021 |
Epidemiologic Studies on Rheumatic Muscle Inflammation, Myositis J Svensson PQDT-Global, 2017 | | 2017 |